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Covered stent grafts are currently used for arterial aneurysm exclusion, aortic dissection, or peripheral occlusive disease.
A new indication to endograft was applied to perform resection of the thoracic aorta for infiltration of an adjacent lung
cancer into the vessel wall, avoiding a major vascular intervention for aortic graft interposition associated with tumor
resection. (J Vasc Surg 2008;47:868-70.)Endografts are currently used in aneurysm exclusion,
aortic dissection, or ruptures as well as in peripheral occlu-
sive disease. This is the first report of a covered stent graft
applied in the thoracic aorta to perform the resection of the
aortic wall infiltrated by a metastatic lung carcinoma in
order to avoid a major vascular intervention and a tradi-
tional vascular graft interposition presenting a significant
morbidity and mortality risk in a patient undergoing a redo
thoracotomy and completion left pneumonectomy.
CASE REPORT
A 61-year-old man had a recurrent metastasis from porocarci-
noma localized in the left lung and infiltrating the aortic wall. In
1995, he underwent a surgical resection of an eccrine porocarci-
noma (EP), a malignant tumor arising from the intraepidermal
portion of sweat gland, localized in the neck region. In 1999, he
underwent a left lower lobectomy for a single lung metastasis from
EP. In December 2005, the patient presented with dyspnea and
persistent cough. A computed tomography (CT) scan showed the
presence of a mass occluding the left main bronchus and infiltrat-
ing the wall of descending aorta (Fig, 1, a). A positron emission
tomography (PET)-CT scan showed an intense uptake in the left
hilum (Fig 1, b), but no other localization of cancer was evident.
Bronchoscopy evidenced the distal infiltration of left main bron-
chus by the tumor, and the biopsy specimen of the mass was
suggestive for a relapsing EP. Because of the local aggressiveness of
tumor, the patient was referred to the oncologist for a chemother-
apeutic treatment. From February to May he underwent three
cycles of chemotherapy.
The new assessment with CT and PET scans showed a partial
response to treatment with resolution of atelectasis (Fig 1, c-d). On
the basis of the chemotherapy response, we planned a surgical
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868resection. Surgical excision of cancer was not feasible without
concomitant resection of the infiltrated aortic wall and thoracic
aorta repair. Traditional repair, consisting of resection and graft
interposition with the option of using a cardiopulmonary bypass,
presented a significant morbidity and mortality risk in a patient
undergoing a redo thoracotomy and completion left pneumonec-
tomy. Therefore, a thoracic endovascular graft (Zenith TX2 Tho-
racic TAA, Cook, Brisbane, Australia), 28-mm diameter and
120-mm length, was placed distal to the left subclavian artery,
covering the area involved by cancer infiltration, with a safe prox-
imal and distal 4-cm margin of normal aorta.
The next day, the patient underwent a completion left pneu-
monectomy together with resection of the infiltrated area of tho-
racic aorta, avoiding aortic clamping, resection, and vascular graft
anastomoses. The removed area included the adventitia and almost
the full thickness of the media, about 3-cm wide of one-quarter of
the aorta circumference (Fig 2, a). Margins were negative of tumor
Fig 1. (a) A computed tomography (CT) scan shows infiltration
of carcinoma into the aortic wall (white arrow), and (b) a positron
emission tomography (PET) scan reveals an intense uptake in the
hilum. After chemotherapy, (c) CT and (d) PET scans show
reduction of the mass and resolution of lung atelectasis.at frozen section examination during surgery.
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tion into the adventitia of the aortic wall (Fig 2, b). The postoper-
ative course was uneventful and the patient was discharged on day
10 (Fig 2, c). Adjuvant radiotherapy was delivered (total dose, 60
Gy) in the area of hilum and aortic invasion. The patient is well and
free of disease 10 months after surgery.
DISCUSSION
Endografts are currently used in aneurysm exclusion,
aortic dissection, ruptures, and in peripheral occlusive dis-
ease. To our knowledge, this is the first report of an
endograft applied to perform the resection of the aortic wall
infiltrated by a metastatic lung carcinoma, thus avoiding a
major vascular intervention and a traditional vascular graft
interposition. Tumors of different origin in the thorax may
invade the aortic wall, and combined resection of the
infiltrated aorta and esophageal,1 lung,2,3 or thymic4 carci-
noma has been done by using temporary cardiopulmonary
or aortoaortic bypass.
Eccrine porocarcinoma is a rare malignant tumor of the
eccrine sweat glands arising from the acrosyringium. The
age at presentation is usually between 50 to 80 years, even
if this tumor frequently remains undiagnosed for many
years before being treated. The most common initial loca-
tion is the lower extremities, followed by trunk, head, and
neck.5 The clinical course of EP is characterized by frequent
local relapses or lymph nodes and systemic metastases.
Distant metastases develop in about 25% of patients, with
the most common sites being the retroperitoneum, perito-
neum, femur, breast, liver, bladder, ovary, adrenal glands,
and lungs.6
Prognosis is poor in patients with recurrent/metastatic
EP. Treatment recommendations for these patients are not
well established owing to the small number of reported
cases. Several chemotherapy and radiation treatments have
been used with variable response rates.7 In the present
patient, the long latency time between the resection of the
primary tumor and the lung metastases, and the partial
response to induction chemotherapy regimen, led us to
consider an aggressive surgical approach involving a com-
pletion pneumonectomy associated with resection of the
infiltrated aortic tissue.
Despite advances in perioperative care, surgical tech-
nique and both total and partial cardiopulmonary bypass, a
combined surgical intervention is still challenging for tho-
racic surgeons and has significant morbidity and mortality.
The most common complications are bleeding, paraplegia,
stroke, cardiac events, pulmonary insufficiency, renal fail-
ure, and the potential of systemic spread of tumor cells.
Complications after cancer resection may add to complica-
tions of thoracic aorta resection and vascular reconstruc-
tion.
Sahasara et al8 performed an experimental study to
investigate whether aortic stent grafting can be applied to
treatment of esophageal cancer involving the thoracic
aorta. The canine thoracic aorta was partially resected,
without the aorta being clamped, after placement of an
endovascular stent graft. An aortic whole layer of 1 cmlength and one-quarter of the circumference or the aorta
adventitia and the outer half of media layer of same exten-
sion was resected in all cases, with no complications. The
authors concluded that an aortic endograft could be ap-
plied in surgery for an esophageal cancer involving the
aorta.
CONCLUSION
Our experience showed that an aortic endograft can be
a useful and safe tool to allow a combined resection of the
lung and the infiltrated aortic wall without the need for
thoracic aorta cross-clamping and graft replacement, po-
tentially reducing morbidity and mortality associated with
surgery. Further studies with longer follow-up are neces-
sary to evaluate the potential of this technique, but we
believe that when a limited area of descending thoracic
aorta is involved by tumor and the resected wall needs to be
replaced with a prosthetic graft, the use of endograft could
represent an appropriate option.
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